Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2018

03.07.2018 | Maternal-Fetal Medicine

An effect of maternal nifedipine therapy on fetoplacental blood flow: a prospective study

verfasst von: Ahmet Namazov, Leonti Grin, Resul Karakus, Mehmet Uludogan, Habibe Ayvaci

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study is to assess the effects of maternal nifedipine administration on placental and fetal blood flow.

Methods

A total of 29 patients with preterm labor diagnosis admitted to the tertiary care center, Zeynep Kamil Hospital, were evaluated. Before and 24–48 h after administration of oral nifedipine, Doppler ultrasound scan was carried out to measure fetal middle cerebral artery, ductus venosus, umbilical artery, and maternal uterine artery blood flow.

Results

After 24 and 48 h of therapy, there were no changes in mean PI and RI in the umbilical arteries and ductus venosus (p > 0.05). Fetal middle cerebral artery and maternal uterine artery PI and RI values showed a significant reduction 24–48 h after oral nifedipine therapy (p < 0.05).

Conclusions

Our study showed that 24 and 48 h after oral nifedipine therapy, there is a significant increase in fetal MCA and maternal uterine artery blood flow, while fetal umbilical artery and ductus venosus Doppler values do not change.
Literatur
1.
Zurück zum Zitat Magowan BA, Bain M, Juszczak E, McInneny K (1998) Neonatal mortality amongst Scottish preterm singleton births (1985–1994). Br J Obstet Gynaecol 105(9):1005–1010CrossRefPubMed Magowan BA, Bain M, Juszczak E, McInneny K (1998) Neonatal mortality amongst Scottish preterm singleton births (1985–1994). Br J Obstet Gynaecol 105(9):1005–1010CrossRefPubMed
2.
Zurück zum Zitat Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR (2000) Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 343(6):378–384CrossRefPubMed Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR (2000) Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 343(6):378–384CrossRefPubMed
3.
Zurück zum Zitat Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH et al (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88(1):31–38CrossRefPubMed Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH et al (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88(1):31–38CrossRefPubMed
4.
Zurück zum Zitat Lau HCQ, Tung JSZ, Wong TTC, Tan PL, Tagore S (2017) Timing of antenatal steroids exposure and its effects on neonates. Arch Gynecol Obstet 296(6):1091–1096CrossRefPubMed Lau HCQ, Tung JSZ, Wong TTC, Tan PL, Tagore S (2017) Timing of antenatal steroids exposure and its effects on neonates. Arch Gynecol Obstet 296(6):1091–1096CrossRefPubMed
5.
Zurück zum Zitat Saigal S, Doyle LW (2008) An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371(9608):261–269CrossRefPubMed Saigal S, Doyle LW (2008) An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371(9608):261–269CrossRefPubMed
6.
Zurück zum Zitat King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 2003(1):CD002255 King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 2003(1):CD002255
7.
Zurück zum Zitat Wagner P, Sonek J, Abele H, Sarah L, Hoopmann M, Brucker S et al (2017) Effectiveness of the contemporary treatment of preterm labor: a comparison with a historical cohort. Arch Gynecol Obstet 296(1):27–34CrossRefPubMed Wagner P, Sonek J, Abele H, Sarah L, Hoopmann M, Brucker S et al (2017) Effectiveness of the contemporary treatment of preterm labor: a comparison with a historical cohort. Arch Gynecol Obstet 296(1):27–34CrossRefPubMed
8.
Zurück zum Zitat Papatsonis DN, Kok JH, van Geijn HP, Bleker OP, Adèr HJ, Dekker GA (2000) Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 95(4):477–481PubMed Papatsonis DN, Kok JH, van Geijn HP, Bleker OP, Adèr HJ, Dekker GA (2000) Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 95(4):477–481PubMed
9.
Zurück zum Zitat Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L et al (1996) The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174(3):823–828CrossRefPubMed Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L et al (1996) The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174(3):823–828CrossRefPubMed
10.
Zurück zum Zitat Kutuk MS, Ozgun MT, Uludag S, Dolanbay M, Yildirim A (2013) Acute pulmonary failure due to pulmonary edema during tocolytic therapy with nifedipine. Arch Gynecol Obstet 288(4):953–954CrossRefPubMed Kutuk MS, Ozgun MT, Uludag S, Dolanbay M, Yildirim A (2013) Acute pulmonary failure due to pulmonary edema during tocolytic therapy with nifedipine. Arch Gynecol Obstet 288(4):953–954CrossRefPubMed
11.
Zurück zum Zitat Luewan S, Mahathep R, Tongsong T (2011) Hypotension in normotensive pregnant women treated with nifedipine as a tocolytic drug. Arch Gynecol Obstet 284(3):527–530CrossRefPubMed Luewan S, Mahathep R, Tongsong T (2011) Hypotension in normotensive pregnant women treated with nifedipine as a tocolytic drug. Arch Gynecol Obstet 284(3):527–530CrossRefPubMed
12.
Zurück zum Zitat Guclu S, Saygili U, Dogan E, Demir N, Baschat AA (2004) The short-term effect of nifedipine tocolysis on placental, fetal cerebral and atrioventricular Doppler waveforms. Ultrasound Obstet Gynecol 24(7):761–765CrossRefPubMed Guclu S, Saygili U, Dogan E, Demir N, Baschat AA (2004) The short-term effect of nifedipine tocolysis on placental, fetal cerebral and atrioventricular Doppler waveforms. Ultrasound Obstet Gynecol 24(7):761–765CrossRefPubMed
13.
Zurück zum Zitat Lima MM, Souza AS, Diniz C, Porto AM, Amorim MM, Moron AF (2009) Doppler velocimetry of the uterine, umbilical and fetal middle cerebral arteries in pregnant women undergoing tocolysis with oral nifedipine. Ultrasound Obstet Gynecol 34(3):311–315CrossRefPubMed Lima MM, Souza AS, Diniz C, Porto AM, Amorim MM, Moron AF (2009) Doppler velocimetry of the uterine, umbilical and fetal middle cerebral arteries in pregnant women undergoing tocolysis with oral nifedipine. Ultrasound Obstet Gynecol 34(3):311–315CrossRefPubMed
14.
Zurück zum Zitat Cornette J, Duvekot JJ, Roos-Hesselink JW, Hop WC, Steegers EA (2011) Maternal and fetal haemodynamic effects of nifedipine in normotensive pregnant women. BJOG 118(4):510–540CrossRefPubMed Cornette J, Duvekot JJ, Roos-Hesselink JW, Hop WC, Steegers EA (2011) Maternal and fetal haemodynamic effects of nifedipine in normotensive pregnant women. BJOG 118(4):510–540CrossRefPubMed
15.
Zurück zum Zitat Harake B, Gilbert RD, Ashwal S, Power GG (1987) Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep. Am J Obstet Gynecol 157(4 Pt 1):1003–1008CrossRefPubMed Harake B, Gilbert RD, Ashwal S, Power GG (1987) Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep. Am J Obstet Gynecol 157(4 Pt 1):1003–1008CrossRefPubMed
16.
Zurück zum Zitat Ducsay CA, Thompson JS, Wu AT, Novy MJ (1987) Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 157(6):1482–1486CrossRefPubMed Ducsay CA, Thompson JS, Wu AT, Novy MJ (1987) Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 157(6):1482–1486CrossRefPubMed
17.
Zurück zum Zitat Csapo AI, Puri CP, Tarro S, Henzl MR (1982) Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine. Am J Obstet Gynecol 142(5):483–491CrossRefPubMed Csapo AI, Puri CP, Tarro S, Henzl MR (1982) Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine. Am J Obstet Gynecol 142(5):483–491CrossRefPubMed
19.
Zurück zum Zitat Guclu S, Gol M, Saygili U, Demir N, Sezer O, Baschat AA (2006) Nifedipine therapy for preterm labor: effects on placental, fetal cerebral and atrioventricular Doppler parameters in the first 48 hours. Ultrasound Obstet Gynecol 27(4):403–408CrossRefPubMed Guclu S, Gol M, Saygili U, Demir N, Sezer O, Baschat AA (2006) Nifedipine therapy for preterm labor: effects on placental, fetal cerebral and atrioventricular Doppler parameters in the first 48 hours. Ultrasound Obstet Gynecol 27(4):403–408CrossRefPubMed
20.
Zurück zum Zitat Chitrit Y, Caubel P, Herrero R, Schwinte AL, Guillaumin D, Boulanger MC (2000) Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. BJOG 107(4):501–507CrossRefPubMed Chitrit Y, Caubel P, Herrero R, Schwinte AL, Guillaumin D, Boulanger MC (2000) Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. BJOG 107(4):501–507CrossRefPubMed
21.
Zurück zum Zitat Kähler C, Schleussner E, Möller A, Seewald HJ (2004) Doppler measurements in fetoplacental vessels after maternal betamethasone administration. Fetal Diagn Ther 19(1):52–57CrossRefPubMed Kähler C, Schleussner E, Möller A, Seewald HJ (2004) Doppler measurements in fetoplacental vessels after maternal betamethasone administration. Fetal Diagn Ther 19(1):52–57CrossRefPubMed
Metadaten
Titel
An effect of maternal nifedipine therapy on fetoplacental blood flow: a prospective study
verfasst von
Ahmet Namazov
Leonti Grin
Resul Karakus
Mehmet Uludogan
Habibe Ayvaci
Publikationsdatum
03.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4839-9

Weitere Artikel der Ausgabe 4/2018

Archives of Gynecology and Obstetrics 4/2018 Zur Ausgabe

Gynecologic Endocrinology and Reproductive Medicine

Galectin-3 as a novel biomarker in women with PCOS

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.